Lam Research Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak in Over a Year — Data Talk
Lam Research Corporation (LRCX) is currently at $655.31, down $8.37 or 1.26%
--Would be lowest close since Aug. 18, 2023, when it closed at $652.94
--Currently down seven consecutive days; down 6.7% over this period
--Longest losing streak since Sept. 6, 2022, when it fell for seven straight trading days
--Worst seven day stretch since the seven days ending Aug. 17, 2023, when it fell 6.82%
--Down 6.7% month-to-date
--Up 55.91% year-to-date
--Down 10.21% from its all-time closing high of $729.82 on Jan. 14, 2022
--Up 55.85% from 52 weeks ago (Sept. 13, 2022), when it closed at $420.48
--Down 9.14% from its 52-week closing high of $721.26 on July 28, 2023
--Up 108.07% from its 52-week closing low of $314.95 on Oct. 14, 2022
--Traded as low as $651.89
--Down 1.78% at today's intraday low
All data as of 11:36:17 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 12, 2023 11:54 ET (15:54 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: Is It Really a Surprising Quarter for Earnings?
-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
How to Invest Like Warren Buffett
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025